 |
|
|
|
|
|
|
 Contact |  Print version |  PDF version |  Send article |  RSS feed
Schering AG files patent infringement lawsuit against Barr Laboratories, Inc. and Barr Pharmaceuticals, Inc.03 May 2005 -
Schering AG, Germany announced that it has, along with its affiliate, Berlex, Inc., filed a patent infringement action against Barr Laboratories, Inc. and its parent company Barr Pharmaceuticals, Inc. relating to Schering AG's YasminŽ (drospirenone and ethinyl estradiol) product.
YasminŽ is the subject of an Abbreviated New Drug Application. Barr Laboratories, Inc. is currently seeking approval from the United States Food and Drug Administration to produce and market a generic version of YasminŽ. The patent infringement lawsuit by Schering AG and Berlex, Inc. was filed in the United States District Court for the District of New Jersey.
Additional information
Bayer Schering Pharma AG
Berlin, Germany
News
|
|
|
|
|
|
Top